Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $29.86 USD
Change Today +0.05 / 0.17%
Volume 669.5K
IMS On Other Exchanges
New York
As of 8:04 PM 06/3/15 All times are local (Market data is delayed by at least 15 minutes).

ims health holdings inc (IMS) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/1/15 - $29.97
52 Week Low
06/18/14 - $23.02
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for IMS HEALTH HOLDINGS INC (IMS)

ims health holdings inc (IMS) Related Businessweek News

View More BusinessWeek News

ims health holdings inc (IMS) Details

IMS Health Holdings, Inc. provides information and technology services to healthcare industry worldwide. Its principal products include national information offerings that provide performance metrics related to the sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity through multiple channels; and sub-national offerings, which offer information related to the measurement of sales at the regional, zip code, and individual prescriber level. The company also provides workflow analytics, a set of strategic, analytic, and support services for life sciences companies; and real-world evidence solutions, which integrate information from medical claims, prescriptions, electronic medical records, biomarkers, and government statistics that provide information about treatment patterns, disease progression, therapeutic switching, and concomitant diseases and treatments. In addition, the company offers a range of hosted and cloud-based applications, and associated implementation services; AnalyticsLink, software as a service based analytics solution; and MIDAS, which acts as a source of insight into international market dynamics. Further, it provides clinical solutions that help biopharmaceutical companies and clinical research organizations to design, plan, execute, and track clinical trials, as well as it integrates client data with company’s information and proprietary analytics that enable risk-sharing and pay-for-performance programs, network design and management, and population health management for payers and providers. The company primarily serves life science companies, including pharmaceutical, biotechnology, consumer health, and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers, and financial communities. IMS Health Holdings, Inc. was founded in 1954 and is based in Danbury, Connecticut.

10,200 Employees
Last Reported Date: 02/13/15
Founded in 1954

ims health holdings inc (IMS) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $1.6M
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $457.5K
Senior Vice President of Global Services
Total Annual Compensation: $426.3K
Senior Vice President of Strategy & Global Pr...
Total Annual Compensation: $410.0K
Senior Vice President of Information Offering...
Total Annual Compensation: $402.0K
Compensation as of Fiscal Year 2014.

ims health holdings inc (IMS) Key Developments

IMS Health Russia and CIS Presents at 2015 Russian Pharmaceutical Forum, May-20-2015 09:00 AM

IMS Health Russia and CIS Presents at 2015 Russian Pharmaceutical Forum, May-20-2015 09:00 AM. Venue: Corinthia Hotel, Saint Petersburg, Russia. Speakers: Nickolai Demidov, General Manager.

IMS Health Holdings, Inc. Presents at UBS Global Healthcare Conference, May-18-2015 08:00 AM

IMS Health Holdings, Inc. Presents at UBS Global Healthcare Conference, May-18-2015 08:00 AM. Venue: Sheraton New York Times Square Hotel, 811 Seventh Avenue, New York, New York, United States. Speakers: Angeliki Cooney, Director.

IMS Health Incorporated Enters into Amendment to its Senior Secured Credit Facility

On May 11, 2015, IMS Health Incorporated entered into an amendment to its senior secured credit facility to borrow $200 million in additional term loans. The proceeds from the additional term loans will be used to fund a portion of the share repurchase. The company intends to fund the share repurchase with the proceeds from the borrowing of additional term loans and borrowings from the company's revolving credit facility and available cash.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMS:US $29.86 USD +0.05

IMS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Informatica Corp $48.47 USD 0.00
Inovalon Holdings Inc $27.34 USD +0.17
PAREXEL International Corp $66.40 USD +0.24
Quintiles Transnational Holdings Inc $69.64 USD -0.04
Teradata Corp $40.00 USD +0.75
View Industry Companies

Industry Analysis


Industry Average

Valuation IMS Industry Range
Price/Earnings 75.2x
Price/Sales 3.8x
Price/Book 5.6x
Price/Cash Flow 17.9x
TEV/Sales 2.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMS HEALTH HOLDINGS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at